The US Oncology Network - Academic Profile

Publications

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Dirk Schadendorf , F. Stephen Hodi , Caroline Robert +7 more

Purpose To provide a more precise estimate of long-term survival observed for ipilimumab-treated patients with advanced melanoma, we performed a pooled analysis of overall survi...

2015 Journal of Clinical Oncology 2068 citations

Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation

Jennifer K. Litton , Hope S. Rugo , Johannes Ettl +15 more

Among patients with advanced breast cancer and a germline BRCA1/2 mutation, single-agent talazoparib provided a significant benefit over standard chemotherapy with respect to pr...

2018 New England Journal of Medicine 1983 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi , Cristina Saura , Toshinari Yamashita +22 more

Trastuzumab deruxtecan showed durable antitumor activity in a pretreated patient population with HER2-positive metastatic breast cancer. In addition to nausea and myelosuppressi...

2019 New England Journal of Medicine 1788 citations

Affiliated Researchers

Neelima Denduluri

The US Oncology Network

Institution Info

Type: other
Country: US
Publications: 3
Citations: 5,839

External Links

Identifiers

ROR: https://ror.org/05xc20j70